The Mission of the ASIP Inflammation/Immunopathology Scientific Interest Group (SIG) is to facilitate the study of the role of infectious, inflammatory, and immunologic processes in cell injury, pathology, and disease. Modulating responses to inflammation, for example as a response to infection or injury or as a suppressor of neoplastic cell growth, is an important aspect of therapeutic approaches. Vaccines and antagonists are being investigated and developed for therapeutic use to provide long-lasting responses.
The objectives of the Inflammation/Immunopathology Scientific Interest Group are:
To investigate the cellular and molecular mechanisms by which cells and tissues cope with infection and inflammation to ultimately develop immunity
To investigate how neoplastic processes escape immune responses and how tumor immunology can be modulated to combat neoplasia
To investigate how dysregulation of inflammation and immunity underlies auto-immune and inflammatory diseases
To foster interactions among scientists investigating mechanisms of inflammation and immunopathology
To provide a forum to discuss recent findings (both published and preliminary unpublished data) related to infection, inflammation, immunity, and how these processes underlie human pathologies
To mentor the next generation of pathologists and scientists interested in inflammatory and immunopathology processes
ASIP Members are invited to participate in the Inflammation/Immunopathology SIG Listserv. Please email membership@asip.org to have your name and email address added to the listserv.
To send a message to the Inflammation/Immunopathology SIG Listserv, send your email to asipinflammation@asip.memberclicks.net. Please note that you must be a member of this listserv in order to send and receive messages.
Please direct all questions to: Lisa McFadden (240) 283-9712.
